Berenholtz Sean M, Pronovost Peter J, Ngo Koni, Barie Philip S, Hitt John, Kuti Joseph L, Septimus Edward, Lawler Nancy, Schilling Lisa, Dorman Todd
Anesthesiology/Critical Care Medicine and Surgery, The Johns Hopkins University, Baltimore, USA.
Jt Comm J Qual Patient Saf. 2007 Sep;33(9):559-68. doi: 10.1016/s1553-7250(07)33060-2.
Sepsis is associated with increased morbidity, mortality, and costs of care. Although several therapies improve outcomes in patients with sepsis, rigorously developed measures to evaluate quality of sepsis care in the intensive care unit (ICU) are lacking.
To select an initial set of candidate measures, in 2003-2004 an interdisciplinary panel reviewed the literature and used a modified nominal group technique to identify interventions that improve outcomes of patients with sepsis in the ICU. Design specifications or explicit definitions for each candidate measure were developed.
Ten potential measures were identified: vancomycin administration, time to vancomycin initiation, broad-spectrum antibiotic administration, time to broad-spectrum antibiotic initiation, blood culture collection, steroid administration, corticotropin stimulation test administration, activated protein C eligibility assessment, activated protein C administration, and vancomycin discontinuation.
The identification of potential measures of quality of care for patients with sepsis can help caregivers to focus on evidence-based interventions that improve mortality and to evaluate their current performance. Further work is needed to evaluate the feasibility and validity of the measures.
脓毒症与发病率、死亡率及护理成本增加相关。尽管有几种疗法可改善脓毒症患者的预后,但缺乏在重症监护病房(ICU)中严格制定的评估脓毒症护理质量的措施。
为了选择一组初始候选措施,在2003 - 2004年,一个跨学科小组回顾了文献,并使用改良的名义群体技术来确定可改善ICU中脓毒症患者预后的干预措施。为每个候选措施制定了设计规范或明确的定义。
确定了10项潜在措施:万古霉素给药、万古霉素开始给药时间、广谱抗生素给药、广谱抗生素开始给药时间、血培养采集、类固醇给药、促肾上腺皮质激素刺激试验给药、活化蛋白C资格评估、活化蛋白C给药以及万古霉素停用。
确定脓毒症患者护理质量潜在措施有助于护理人员关注可改善死亡率的循证干预措施,并评估他们目前的表现。需要进一步开展工作来评估这些措施的可行性和有效性。